Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Glioblastoma Multiforme”

494 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 494 results

Testing effectiveness (Phase 2)Ended earlyNCT03363659
What this trial is testing

Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme

Who this might be right for
GlioblastomaGlioblastoma Multiforme
Wake Forest University Health Sciences 15
Not applicableStudy completedNCT00005082
What this trial is testing

Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT01854554
What this trial is testing

Glioblastoma Multiforme (GBM) Proton vs. Intensity Modulated Radiotherapy (IMRT)

Who this might be right for
Brain Cancer
M.D. Anderson Cancer Center 90
Not applicableUnknownNCT03869242
What this trial is testing

NovoTTF-200A Together With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed GBM

Who this might be right for
Glioblastoma
Tel-Aviv Sourasky Medical Center 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03862430
What this trial is testing

NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM

Who this might be right for
Glioblastoma Multiforme
NuvOx LLC 87
Large-scale testing (Phase 3)Study completedNCT00807027
What this trial is testing

Clinical Trial to Assess the Efficacy and Safety of 'Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea

Who this might be right for
Glioblastoma
GC Cell Corporation 180
Early research (Phase 1)Study completedNCT00626483
What this trial is testing

Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia

Who this might be right for
Malignant Neoplasms Brain
Gary Archer Ph.D. 34
Early research (Phase 1)Looking for participantsNCT06894979
What this trial is testing

Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma

Who this might be right for
Childhood AstrocytomaChildhood Diffuse Intrinsic Pontine GliomaChildhood Diffuse Midline Glioma+2 more
Children's Oncology Group 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT02179086
What this trial is testing

Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
NRG Oncology 606
Testing effectiveness (Phase 2)Looking for participantsNCT05864534
What this trial is testing

Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma

Who this might be right for
Newly Diagnosed GlioblastomaGlioblastoma, Isocitric Dehydrogenase (IDH)-WildtypeGliosarcoma+1 more
Northwestern University 25
Testing effectiveness (Phase 2)Study completedNCT01465347
What this trial is testing

Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaGBMGlioma
Diffusion Pharmaceuticals Inc 59
Testing effectiveness (Phase 2)Ended earlyNCT01898273
What this trial is testing

Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Cellectar Biosciences, Inc. 7
Not applicableLooking for participantsNCT07375992
What this trial is testing

Music Therapy in Newly Diagnosed Glioblastoma After Chemoradiation Therapy (MELODY-GBM)

Who this might be right for
Feasibility Studies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Testing effectiveness (Phase 2)UnknownNCT00006460
What this trial is testing

Radiation Therapy Plus Hyperbaric Oxygen in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Barrett Cancer Center
Large-scale testing (Phase 3)Study completedNCT02573324
What this trial is testing

ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification

Who this might be right for
GlioblastomaGliosarcoma
AbbVie 691
Testing effectiveness (Phase 2)Study completedNCT00525525
What this trial is testing

Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma

Who this might be right for
GlioblastomaGliosarcoma
University of California, San Francisco 74
Early research (Phase 1)Study completedNCT01729260
What this trial is testing

Mebendazole in Newly Diagnosed High-Grade Glioma Patients Receiving Temozolomide

Who this might be right for
Newly Diagnosed High-Grade Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT03581292
What this trial is testing

Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations

Who this might be right for
Anaplastic AstrocytomaGlioblastomaMalignant Glioma
National Cancer Institute (NCI) 38
Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07439172
What this trial is testing

Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma.

Who this might be right for
High Grade GliomasGlioblastomaAstrocytoma+1 more
The Cooper Health System 70
Load More Results